This site is intended for healthcare professionals
  • Home
  • /
  • Journals
  • /
  • Uncategorised Disease
  • /
  • Bevacizumab specifically decreases elevated levels...

Bevacizumab specifically decreases elevated levels of circulating KIT+CD11b+ cells and IL-10 in metastatic breast cancer patients.

Read time: 1 mins
Published:25th Mar 2020
Author: Cattin S, Fellay B, Pradervand S, Trojan A, Ruhstaller T, R�egg C et al.
Source: Oncotarget
Ref.:Oncotarget. 2016 Jan 31.
Register for free access to this exclusive healthcare learning resource

Why sign up with Medthority?

Develop your knowledge with our disease and condition focused Learning Zones

Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines 

Personalised dashboard providing updates and recommendations for content within your areas of interest